<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"BRAF":2,
"NIFTP":3,
"RAS":2,
"Thyroid neoplasm":1,
"Cricohyoidoepiglottopexy":1,
"Mucosal defects":1,
"Supracricoid partial laryngectomy":1,
"Thyroid gland flap":1,
"Wound infection":1,
"Defensive medicine":1,
"Healthcare system":1,
"Magnetic resonance imaging":2,
"Medical practice":1,
"Oversimplifying":1,
"Overtreatment":1,
"Diagnostic pitfall":1,
"Hyalinizing trabecular tumor":1,
"Immunocytochemistry":1,
"Molecular testing":1,
"PAX8/GLIS 1-3 rearrangement":1,
"Thyroid":9,
"Cancer survival analysis":1,
"lincRNA":1,
"non-coding RNA":1,
"pseudogene":1,
"Anthropogenic radionuclides":1,
"Biogeochemical optimum":1,
"Endemic diseases of geochemical origin":1,
"Health risk maps":1,
"Iodine":3,
"Radiation":1,
"epidemiology":2,
"thyroid cancer":22,
"Cribriform-morular papillary carcinoma":1,
"Ectopia":1,
"Lingual thyroid":1,
"Thyroglossal duct carcinoma":1,
"Colombia":1,
"Geographical difference":1,
"South Korea":1,
"Turkey":1,
"Masson's tumor":1,
"clivus":1,
"intravascular papillary endothelial hyperplasia":1,
"petrous bone":1,
"psammoma bodies":1,
"Genetic diseases":1,
"Genetics":1,
"Oncology":3,
"RNA processing":1,
"Thyroid disease":1,
"Foxp3":1,
"Treg":1,
"breast cancer":3,
"Case report":5,
"Endocrine surgery":1,
"General surgery":1,
"Papillary thyroid carcinoma":18,
"Thyroglossal duct cyst":1,
"Lymph node metastasis":5,
"Papillary thyroid microcarcinoma":1,
"Risk factors":2,
"airway":1,
"laryngoplasty":1,
"rhTSH":1,
"Thyroid nodule":6,
"Ultrasound-based TI-RADS classification":1,
"shear wave elastography":2,
"Differentiated thyroid cancer":2,
"Health-related quality of life":1,
"Iodine-131":1,
"Radioiodine therapy":2,
"Thyroid carcinoma":11,
"Downstaging":1,
"Prevalence":1,
"TNM-8":1,
"WHO 2017":1,
"Head and neck surgery":1,
"Otolaryngology":1,
"Robotic platform":1,
"Robotic surgery":1,
"Technology":1,
"Transoral robotic surgery":1,
"anaplastic thyroid carcinoma":3,
"chemoradiation":2,
"chemotherapy":1,
"national cancer data base":1,
"radiation therapy":1,
"BRAF- and RAS-like signaling":1,
"BRAFV600E":3,
"CAFs":1,
"senescent cells":1,
"Thyroid Imaging and Reporting Data System":1,
"malignancy risk stratification":1,
"thyroid ultrasonography":1,
"overall survival":2,
"subcellular localization":1,
"thyroid hormone receptor beta 1":1,
"Asia":1,
"International cooperation":1,
"Oceania":1,
"Radiology":1,
"Screening":1,
"Biopsy, fine-needle":2,
"Cytology":4,
"Frozen sections":1,
"Poorly differentiated thyroid carcinoma":2,
"competitive endogenous RNAs network":1,
"esophageal squamous cell carcinoma":1,
"head and neck squamous cell carcinoma":2,
"prognosis":8,
"weighted gene co-expression network analysis":1,
"adverse effects":1,
"childhood cancer":1,
"differentiated thyroid carcinoma":3,
"fertility":1,
"radioiodine":2,
"Biomarker":3,
"Follicular thyroid adenoma":1,
"Follicular thyroid carcinoma":2,
"ROC curve analysis":1,
"Real-time PCR":1,
"microRNA":2,
"SEER":1,
"incidence":1,
"thyroid cancer subtypes":1,
"fine-needle aspiration":4,
"medullary thyroid carcinoma":6,
"ultrasound":3,
"2020":3,
"Adult":3,
"Female":3,
"Gynaecology":1,
"March":1,
"Unique/unexpected symptoms or presentations of a disease":2,
"White":2,
"hyperthyreosis":1,
"hypophysis adenoma":1,
"hypophysisadenoma":1,
"hypophysisműtét":1,
"pituitary surgery":1,
"collagen protein":1,
"fibrosis":1,
"platelet-derived growth factor":1,
"Adsorption":1,
"Ag(2)O":1,
"Controlled-transforming":1,
"Heterostructured framework":1,
"complications":1,
"elderly patients":1,
"geriatric":1,
"head and neck cancer":1,
"surgery":2,
"Thyroid transcription factor 1 (TTF-1)":1,
"lung adenocarcinomas":1,
"pemetrexed":1,
"Bone":2,
"Fat":1,
"Intraosseous lipoma":1,
"MRI":2,
"Plasmacytoma":1,
"endoscopic thyroidectomy":1,
"oncoplastic thyroid surgery":1,
"remote access thyroidectomy":1,
"transoral thyroidectomy":1,
"AKT":1,
"angiopoietin-like 4":1,
"proliferation":3,
"FSTL1":1,
"hsa_circ_0011290":1,
"miR-1252":1,
"Central neck lymph node dissection":1,
"Hypocalcemia":2,
"Hypoparathyroidism":1,
"Thyroidectomy":3,
"Bethesda system":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"Risk of malignancy (ROM)":1,
"Ectopic":1,
"Parathyroid carcinoma":1,
"Pericardium":1,
"Bilateral disease":1,
"Risk factor":1,
"AZD8055":1,
"Long non-coding RNA":3,
"Papillary thyroid cancer":9,
"SNHG3":1,
"mTOR":2,
"DAPK":1,
"DNA methylation":2,
"PTEN":1,
"diagnosis":3,
"thyroid nodules":1,
"Incidental findings":1,
"Malignancy":1,
"Primary hyperparathyroidism":1,
"SPECT-CT":1,
"Sestamibi":1,
"miR-146b-5p":1,
"smad4":1,
"AKT/mTOR/HK2":1,
"ANP32E":1,
"Glycolysis":1,
"TTF-1":1,
"papillary tumour":1,
"pituitary gland":1,
"sella":1,
"cytopathology":1,
"molecular diagnostic techniques":1,
"pathology":1,
"thyroid neoplasms":9,
"Distant metastasis":1,
"Radioactive iodine therapy":2,
"Tyrosine kinase inhibitors":1,
"Lymphatic metastasis":2,
"thyroglobulin":2,
"accessory nerve":1,
"neck dissection":2,
"neck metastasis":1,
"sublevel IIb":1,
"cervical lymph node metastasis":1,
"level 1b":1,
"oral squamous cell carcinoma":1,
"submandibular gland":1,
"survival analysis":1,
"iodination of salt":1,
"survival":3,
"treatment":2,
"Intraoperative neuromonitoring":1,
"Superior laryngeal nerve":1,
"Transoral endoscopic thyroidectomy":1,
"Vestibular approach":1,
"Adrenal":1,
"Biopsy":1,
"Breast cancer*":1,
"CT scan":1,
"Chromogranin A":1,
"Cytokeratins*":1,
"DIPNECH*":1,
"Dyspnoea":1,
"Haematoxylin and eosin staining":1,
"Histopathology":2,
"Immunohistochemistry":5,
"Levothyroxine":1,
"May":1,
"Molecular genetic analysis":1,
"Neuroendocrine tumour":1,
"New disease or syndrome: presentations/diagnosis/management":1,
"PET scan":1,
"Paraganglioma":1,
"Portugal":1,
"Pulmonary biopsy*":1,
"Resection of tumour":1,
"S-100 protein*":1,
"Synaptophysin":1,
"Thyroxine (T4)":1,
"Wheezing":1,
"apoptosis":3,
"miR-155-5p":1,
"thyroid follicular carcinoma":1,
"Spinal dumbbell tumor":1,
"ectopic thyroid":1,
"thyroid dysgenesis":1,
"Epidermal growth factor receptor":1,
"Fucosyltransferase VII":1,
"Glycosylation":1,
"Migration":3,
"Biopsy, fine needle":1,
"Guideline":1,
"Thyroid cancer, papillary":2,
"Ultrasonography":2,
"mitochondria":1,
"mitochondria-eating protein":1,
"mitophagy":1,
"oncocytic cell tumor":1,
"J-kindred":1,
"early thyroidectomy":1,
"medullary thyroid cancer":2,
"multiple endocrine neoplasia 2A":1,
"prophylactic thyroidectomy":1,
"Vitamin D deficiency":1,
"Central compartment":1,
"Lymph node metastases":1,
"Metabolic imbalance":1,
"Metabonomics":1,
"Parthenolide":1,
"131I therapy":1,
"Pediatric patients":1,
"Rapamycin":1,
"Resveratrol":1,
"Xenograft":1,
"Nuclear versus cytoplasmic":1,
"Ovarian cancer":1,
"Thyroid hormone receptor":1,
"Chromosomal translocation":1,
"FOXP1":1,
"MALT lymphoma":1,
"Thyroid lymphoma":1,
"t(3":1,
"14)(p14 1":1,
"q32)/FOXP1-IGH":1,
"C-cell dedifferentiation":1,
"CA 19 9":1,
"CD133":1,
"MEN2":1,
"RET":1,
"Bone metastases":1,
"Femur":1,
"Macrofollicular variant of papillary thyroid carcinoma":1,
"DTC":1,
"I-131":1,
"RAI":1,
"UCA1":1,
"cancer":2,
"regulatory mechanism":1,
"therapy":1,
"Autoimmunity":1,
"Gender":1,
"Hormones":1,
"Immune checkpoint":2,
"Tfh cells":1,
"metastasis":3,
"ERK signaling":1,
"epithelial-mesenchymal transition":1,
"interleukin-34":1,
"bone mineral density":1,
"thyrotropin suppressive therapy":1,
"trabecular bone score":1,
"diffusion magnetic resonance imaging":1,
"feasibility studies":1,
"nomograms":1,
"Deep neural networks":1,
"Dual energy CT":1,
"Machine learning":1,
"Radiomics":2,
"Spectral CT":1,
"Texture analysis":1,
"Thyroid cartilage invasion":1,
"COVID-19":1,
"Diagnostic Imaging":1,
"Head And Neck Neoplasms":1,
"Squamous Cell Carcinoma Of Head And Neck":1,
"Hashimoto disease":1,
"Macrophages":1,
"T-lymphocytes":1,
"amide proton transfer (APT)":1,
"differentiation":1,
"diffusion-weighted imaging (DWI)":1,
"predominantly solid thyroid adenomatous nodule":1,
"Allergic acute tubulointerstitial nephritis":1,
"Tyrosine kinase inhibitor":1,
"Vandetanib":1,
"salivary glands":1,
"sialadenitis":1,
"xerostomia":1,
"CTLA4":1,
"PD-1":1,
"PD-L1":2,
"PD-L2":1,
"BRAF mutation":2,
"Aggressive papillary thyroid carcinoma":1,
"Diagnostic markers":1,
"Receiver operating characteristic curve":1,
"microRNA-221/222":1,
"qRT-PCR":1,
"Epidermal growth factor receptor (EGFR) mutation":1,
"endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) and biopsy (FNB)":1,
"lung adenocarcinoma":1,
"pancreatic ductal carcinoma":1,
"RNA RP11-480I12 5":1,
"invasion":3,
"Hurthle cell":1,
"melanoma":1,
"skin neoplasm":1,
"Cancer management":1,
"Metastatic disease":1,
"Skeletal-related event":1,
"Body constitution":1,
"Clinical study":1,
"Medicine, Chinese traditional":1,
"Review":1,
"AUS/FLUS":1,
"RoM":1,
"atypia of undetermined significance":1,
"fine needle aspiration":1,
"SEER database":1,
"adjuvant radiation":1,
"external beam radiation":1,
"radiotherapy":1,
"Anaplastic transformation":1,
"Intestinal perforation":1,
"Peritoneal metastasis":1,
"Metastases":1,
"Halszysten":1,
"Lymphknoten-Tuberkulose":1,
"Lymphom":1,
"Schilddrüsenknoten":1,
"Speicheldrüsen-Tumoren":1,
"Thyroid nodes":1,
"Veränderungen der Tonsillen":1,
"cervical cysts":1,
"changes in the tonsils":1,
"lymph node tuberculosis":1,
"lymphoma":1,
"salivary gland tumors":1,
"HDL ant-oxidative capacity":1,
"HDL cholesterol":1,
"HDL subfractions":1,
"cholesterol efflux capacity":1,
"hypothyroidism":1,
"nuclear magnetic resonance":1,
"Bioinformatics":1,
"TCGA":1,
"prognostic markers":1,
"stemness":1,
"Ankylosing spondylitis":1,
"Anti-phospholipid syndrome":1,
"Autoimmune hemolytic anemia":1,
"Idiopathic thrombocytopenic purpura":1,
"IgA nephropathy":1,
"Multiple sclerosis":2,
"Polyarteritis nodosa":1,
"Polymyositis":1,
"Sarcoidosis":1,
"Temporal arteritis":1,
"Pi3k/AKT pathway":1,
"microarray analysis":1,
"siRNA":1,
"laryngeal neoplasms":2,
"multicentric study":1,
"paraglottic space":1,
"total laryngectomy":1,
"tumor thickness":1,
"Clinical prognostic model":1,
"Metastatic epidural spinal cord compression":1,
"Quality of life":1,
"Carcinoma de tiroides":1,
"Linfadenectomía":1,
"Lymphadenectomy":1,
"Metástasis linfática":1,
"OSNA":1,
"drug utilization":1,
"process assessment":1,
"Oral semaglutide":1,
"clinical practice":1,
"glucagon-like peptide-1 receptor agonist":1,
"guidelines":1,
"primary care":1,
"type 2 diabetes":1,
"TERT promoter":1,
"3D culture":1,
"Anaplastic thyroid cancer":1,
"Collagen":1,
"MT1-MMP":1,
"August":1,
"Israel":1,
"Other":1,
"NF-E2-related factor 2":1,
"goiter":1,
"microRNAs":2,
"vascular endothelial growth factor A":1,
"Incidentally":1,
"Squamous cell carcinoma":2,
"Tongue cancer":1,
"Research progress":1,
"BRAF gene":2,
"contrast-enhanced ultrasound":2,
"extrathyroidal extension":1,
"contrast enhanced ultrasound (CEUS)":1,
"primary squamous cell carcinoma":1,
"thyroid nodules (TNs)":1,
"thyroid ultrasound (US)":1,
"X-ray computed":1,
"gastric cancer":1,
"sarcomatoid carcinoma":1,
"stomach":1,
"tomography":1,
"Extrapulmonary small cell carcinoma":1,
"external auditory canal":1,
"liver metastasis":1,
"thyroid transcription factor 1":1,
"AP-1":1,
"JAZF1":1,
"TFAP2B":1,
"Meta-analysis":1,
"Mortality":1,
"Neoplasm staging":1,
"Cancer incidence":1,
"Cancer mortality":1,
"Digital radiography":1,
"Effective dose":1,
"Lifetime attributable risk":1,
"Organ dose":1,
"CD26":1,
"Capsular invasion":1,
"Follicular variant of papillary thyroid carcinoma":1,
"CCDC6-RET":1,
"KIF5B-RET":1,
"Non-small cell lung cancer":1,
"RET inhibitor":1,
"Structure-activity relationship":1,
"DICER1":1,
"follicular neoplasm":1,
"calcitonin":2,
"disease-modifying therapy":1,
"human herpesvirus 4":1,
"interferon β-1b":1,
"thyroid collision tumors":1,
"Breast neoplasms":1,
"FHL1 protein, human":1,
"Neoplasm metastasis":1,
"differentially expressed proteins":1,
"invasiveness":1,
"markers":1,
"tandem-mass tag":1,
"infrequent metastatic sites":1,
"long survival":1,
"subcutaneous metastasis":1,
"FBXW":1,
"Prostate cancer":1,
"gene amplification":1,
"mCRPC":1,
"Contralateral occult carcinoma":1,
"lymph node metastasis (LNM)":1,
"multifocality":1,
"papillary thyroid carcinoma (PTC)":2,
"Immunotherapy":2,
"metabolism":1,
"tumor associated macrophages":1,
"tumor microenvironment (TME)":1,
"G protein-coupled estrogen receptor":1,
"GPER":1,
"GPR30":1,
"estrogen":1,
"estrogen receptor":1,
"female reproductive cancers":1,
"hormone":1,
"Giant cells":1,
"Pleomorphic carcinoma":1,
"Undifferentiated":1,
"fluorodeoxyglucose F18":1,
"positron emission tomography":1,
"lymph node":1,
"ThyraMIR":1,
"fine-needle aspiration (FNA)":1,
"medullary thyroid cancer (MTC)":1,
"microRNA (miRNA)":1,
"EPIC":1,
"biomarkers":1,
"nested case–control study":1,
"polyphenol":1,
"local recurrence":1,
"flow cytometry":1,
"papillary carcinoma":1,
"xenografted mice":1,
"clinical decision-making":1,
"lymph node excision":1,
"lymph nodes":1,
"Depth of invasion":1,
"Head and neck":1,
"Mouth":1,
"Neoplasm":1,
"hypocalcaemia":1,
"recurrent laryngeal nerve paralysis":1,
"thyroid lobectomy":1,
"total thyroidectomy":1,
"SNP":1,
"VDBP":1,
"[25(OH)D]":1,
"single nucleotide polymorphism":1,
"vitamin D":1,
"vitamin D binding protein":1,
"IMRT":1,
"VMAT":1,
"flattening filter free":1,
"localized prostate cancer":1,
"secondary malignancy risk":1,
"Long non-coding RNA (lncRNA)":1,
"anaplastic":2,
"oncogenesis":1,
"Follicular variant papillary thyroid carcinoma":1,
"classical variant papillary thyroid carcinoma":1,
"nuclear medicine":1,
"radioactive iodine":1,
"remnant ablation":1,
"Aspiration cytology":1,
"Mair's score":1,
"fine-needle aspiration cytology":1,
"nonaspiration":1,
"pneumothorax":1,
"targeted molecular therapy":1,
"Rearranged during Transfection (RET)":1,
"Sporadic medullary thyroid carcinoma (MTC)":1,
"genetic alteration":1,
"immune microenvironment":1,
"multikinase inhibitor":1,
"targeting therapy":1,
"Thailand":1,
"immunohistochemistry (IHC)":1,
"tissue microarray":1,
"katanin P60":1,
"katanin P80":1,
"tumor stage":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年8月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
